48 related articles for article (PubMed ID: 11766333)
1. [Experimental systems in CML biology].
Maru Y
Nihon Rinsho; 2001 Dec; 59(12):2322-8. PubMed ID: 11766333
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.
Park J; Kim KI; Koh Y; Won NH; Oh JM; Lee DS; Kim BK; Ahn KS; Yoon SS
Exp Hematol; 2010 Sep; 38(9):773-81. PubMed ID: 20438801
[TBL] [Abstract][Full Text] [Related]
3. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
4. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
Beran M; Pisa P; O'Brien S; Kurzrock R; Siciliano M; Cork A; Andersson BS; Kohli V; Kantarjian H
Cancer Res; 1993 Aug; 53(15):3603-10. PubMed ID: 8339266
[TBL] [Abstract][Full Text] [Related]
5. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
McGuirk J; Yan Y; Childs B; Fernandez J; Barnett L; Jagiello C; Collins N; O'Reilly RJ
Bone Marrow Transplant; 1998 Aug; 22(4):367-74. PubMed ID: 9722072
[TBL] [Abstract][Full Text] [Related]
6. Blast crisis in a murine model of chronic myelogenous leukemia.
Daley GQ; Van Etten RA; Baltimore D
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11335-8. PubMed ID: 1763047
[TBL] [Abstract][Full Text] [Related]
7. The biology of chronic myelogenous leukemia:mouse models and cell adhesion.
Wertheim JA; Miller JP; Xu L; He Y; Pear WS
Oncogene; 2002 Dec; 21(56):8612-28. PubMed ID: 12476308
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
11. Model mice for BCR/ABL-positive leukemias.
Honda H; Hirai H
Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
13. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
14. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.
Ren R
Oncogene; 2002 Dec; 21(56):8629-42. PubMed ID: 12476309
[TBL] [Abstract][Full Text] [Related]
17. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
18. A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.
Skórski T; Nieborowska-Skórska M; Calabretta B
Folia Histochem Cytobiol; 1992; 30(3):91-6. PubMed ID: 1286728
[TBL] [Abstract][Full Text] [Related]
19. Propagation of human blastic myeloid leukemias in the SCID mouse.
Sawyers CL; Gishizky ML; Quan S; Golde DW; Witte ON
Blood; 1992 Apr; 79(8):2089-98. PubMed ID: 1562735
[TBL] [Abstract][Full Text] [Related]
20. Allosterically controllable maxizyme-mediated suppression of progression of leukemia in mice.
Kuwabara T; Tanabe T; Warashina M; Xiong KX; Tani K; Taira K; Asano S
Biomacromolecules; 2001; 2(4):1220-8. PubMed ID: 11777396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]